Altamira Therapeutics Ltd.: xbrl:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset
| Value | {"unit": "CHF", "value": -1792265} |
|---|---|
| Period | 2018-01-01 – 2018-12-31 |
| Status | current |
| Entity | Altamira Therapeutics Ltd. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:24:22.861909+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/39ec921b-8f04-4605-a26c-4507375d6fc2
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-20-009292Retrieved: 2026-08-19T16:24:22.861909+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Cite as: FACTANKER, https://factanker.com/fact/39ec921b-8f04-4605-a26c-4507375d6fc2
History
- supersedes {"unit": "CHF", "value": 1792265} (evidence 0001601936-19-000008)